Researchers in Switzerland and Australia have brought together the physics of dielectric metasurfaces and hyperspectral imaging to create an ultrasensitive, label-free biosensing platform (Nat. Photon., doi: 10.1038/s41566-019-0394-6).
The team believes that the platform—reportedly capable of detecting and analyzing samples at spatial concentrations of less than three molecules per square micron—could ultimately enable compact portable diagnostics for personalized medicine. It could also, according to the researchers, offer a route to high-throughput, high-resolution optical characterization of single-atom-thick, 2-D materials such as graphene, a key requirement for advancing the technical development of those much-ballyhooed materials.